PRAX (Praxis Precision Medicines Inc) Yalpi foyda bo'yicha rentabellik

Praxis Medicines (PRAX) kompaniyasining rasmiy ramzlari

Geosiyosiy to'lqinlanishlar neyropreparatlar yetkazib berishni falaj qilishi mumkin, biroq pudratchilarni diversifikatsiya qilish bunday xavflarni minimallashtiradi. GURU.Markets grafigidagi yalpi foyda marjasi ushbu ziddiyatni yumshatadi, bunda 0.00 ko'rsatkichi ushbu darajani belgilaydi. Yakuniy nuqtada, Praxis Precision Medicines (PRAX) ventura modeliga tayanadi: molekula bozorga olib chiqilgach, markaziy nerv tizimi bo'yicha ulkan xarajatlar superfoyda bilan almashtiriladi.

PRAX Praxis Precision Medicines, Inc. Yalpi rentabellik (04.07.2022 - 20.11.2026)

Praxis Precision Medicines Inc (PRAX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- biznesning bozor baholash ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Praxis Medicines
Praxis Precision Medicines, Inc. seriyali mahsuloti

Investorlar Praxis Precision Medicines (PRAX) faoliyatini baholash uchun ob'ektiv fundamental mezonlarga ehtiyoj sezmoqdalar. Yillik yalpi foyda marjasi bevosita ishlab chiqarish xarajatlari chegirib tashlanganidan keyin qolgan daromad qismini o'lchaydi, bu esa yillik yalpi foyda marjasiga innovatsion terapiya xarajatlarini sezilarli darajada oshiradigan geosiyosiy zarbalar natijasida yuzaga kelgan faol moddalar ta'minot zanjiridagi uzilishlar kabi operatsion xavflarni aniqlash imkonini beradi.

Muhim raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja AXSM|Yalpi foyda bo'yicha rentabellik ACADIA Pharmaceuticals ACAD|Yalpi marja XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Yalpi foyda bo'yicha marjinallik|SUPN - Yalpi rentabellik|Catalyst Pharmaceuticals Inc (CPRX) - Yalpi foyda bo'yicha rentabellik|DNLI (Denali Corp) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi harmonybiosciences.com (HRMY)|Yalpi foyda bo'yicha rentabellik BHVN|Yalpi marja Amylyx|Yalpi marja TRVI|Anavex Corp - Sotuvning yalpi rentabelligi|Yalpi rentabellik CeriBell CBLL|Yalpi foyda bo'yicha sotuv rentabelligi Prothena Biosciences (PRTA)|ALEC: Yalpi foyda bo'yicha rentabellik|ANNX - Yalpi marja|Omeros Corp. (OMER) - Yalpi rentabellik|Yalpi foyda marjasi Neurogene Inc. (NGNE)|Yalpi foyda bo'yicha rentabellik ACIU|Yalpi rentabellik VYGR|Yalpi rentabellik Neumora (NMRA)|SCLX - Yalpi foyda marjasi|Yalpi marja TVGN (Tevogen Bio Holdings Inc.)|Yalpi foyda normasi ACOG|Cognition Therapeutics Inc. - Yalpi marja|IKT - Yalpi marja|SAVA: Yalpi marja|Assertio Holdings, Inc. - Yalpi foyda normasi|COYA (Coya) - Yalpi marja|Sotuvning yalpi rentabelligi VTGN (Vistagen Therapeutics)|Yalpi rentabellik Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik CervoMed, Inc. CRVO|Yalpi marja Alterity Therapeutics ATHE|CLNN: Yalpi foyda bo'yicha rentabellik|PEPG (pepgen.com) - Sotuvning yalpi rentabelligi|Jupiter Neurosciences Inc (JUNS) - Yalpi rentabellik|Relmada Therapeutics - Yalpi foyda normasi|ANVS (Annovis Bio Inc) - Yalpi marja|GRCE: Yalpi foyda normasi|Yalpi rentabellik Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Yalpi foyda normasi|Yalpi rentabellik neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Yalpi foyda marjasi|MTVA: Yalpi foyda bo'yicha rentabellik|NeurAxis, Inc (NRXS) - Yalpi foyda bo'yicha rentabellik|HSDT: Yalpi marja|PASG - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Neuphoria Therapeutics, Inc.|Yalpi rentabellik NERV|Yalpi marja ATHA|ADXN (Addex Therapeutics Ltd) - Yalpi foyda normasi|Yalpi rentabellik alzamend.com ALZN|Yalpi foyda bo'yicha sotuv rentabelligi Cyclerion Therapeutics (CYCN)|Protagenic - Yalpi marja|Yalpi foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Yalpi marja|Avenue Therapeutics Inc. (ATXI) - Yalpi marja|BCLI (BrainStorm Cell Therapeutics Inc.) - Yalpi marja|Yalpi marja Cara Therapeutics Inc|Yalpi rentabellik Chromocell Therapeutics (CHRO)|Yalpi foyda koeffitsiyenti ELYM|Yalpi rentabellik Intra-Cellular ITCI|LBPH: Sotuvning yalpi rentabelligi|MRNS - Yalpi rentabellik|NKGen Biotech, Inc. (NKGN) - Yalpi foyda bo'yicha rentabellik|neurobopharma.com (NRBO) - Yalpi rentabellik|SAGE: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)